Spleen News and Research

RSS
Columbia University's imaging software gets FDA 510k clearance

Columbia University's imaging software gets FDA 510k clearance

Gaucher disease: an interview with Dr Clement Olivier, Shire

Gaucher disease: an interview with Dr Clement Olivier, Shire

Chrysophanol protects against learning and memory impairments in lead-exposed adult mice

Chrysophanol protects against learning and memory impairments in lead-exposed adult mice

New potential avenues to predict and prevent ovarian cancer metastasis

New potential avenues to predict and prevent ovarian cancer metastasis

CTI completes recruitment in PERSIST-1 clinical trial of pacritinib for treatment of myelofibrosis

CTI completes recruitment in PERSIST-1 clinical trial of pacritinib for treatment of myelofibrosis

New device could offer more reliable alternative for detecting biomarkers

New device could offer more reliable alternative for detecting biomarkers

Researchers review effectiveness of RDTs in diagnosing visceral leishmaniasis

Researchers review effectiveness of RDTs in diagnosing visceral leishmaniasis

Enhancing vaccine efficiency through encapsulation

Enhancing vaccine efficiency through encapsulation

New insight into how malaria parasites perturb flow may lead to novel treatments

New insight into how malaria parasites perturb flow may lead to novel treatments

Researchers reveal mysterious behavior of individual cells using radioluminescence microscopy

Researchers reveal mysterious behavior of individual cells using radioluminescence microscopy

Incyte’s ruxolitinib Phase III study for polycythemia vera achieves primary endpoint

Incyte’s ruxolitinib Phase III study for polycythemia vera achieves primary endpoint

Promedior reports positive preliminary data from PRM-151 Phase 2 trial for myelofibrosis

Promedior reports positive preliminary data from PRM-151 Phase 2 trial for myelofibrosis

Peptide antibodies hit immune-response-stifling MDSCs without harming other vital cells

Peptide antibodies hit immune-response-stifling MDSCs without harming other vital cells

French researchers introduce new method to effectively control bleeding and repair tissues

French researchers introduce new method to effectively control bleeding and repair tissues

Nanotechnology unlocks new pathways for targeted drug delivery

Nanotechnology unlocks new pathways for targeted drug delivery

Inhibiting cancer-promoting prolactin causes unconventional cell death in preclinical research

Inhibiting cancer-promoting prolactin causes unconventional cell death in preclinical research

Study examines events that lead to sepsis by Streptococcus pneumoniae

Study examines events that lead to sepsis by Streptococcus pneumoniae

Gut bacteria and blood cell development relationship helps immune system fight infection

Gut bacteria and blood cell development relationship helps immune system fight infection

Incyte Corporation publishes results of Phase III trial of ruxolitinib in patients with polycythemia vera

Incyte Corporation publishes results of Phase III trial of ruxolitinib in patients with polycythemia vera

Cell Therapeutics initiates Phase 3 clinical trial to evaluate pacritinib in patients with myelofibrosis

Cell Therapeutics initiates Phase 3 clinical trial to evaluate pacritinib in patients with myelofibrosis

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.